| abstract |
An antimicrobial preparation of D-7-[ alpha -(4-hydrooxy-6-methylnicotinamido)-4-hydroxyphenylacetamido]-3-(1-meth yltetrazol-5-yl)thiomethyl- DELTA 3-cephem-4-sodium carboxylate (hereinafter referred to as "Compound A" of enhanced stability is disclosed, which comprises a microbially effective amount of Compund A and a stabilizer selected from the class consisting of benzoic acid, sodium benzoate and nicotinamide. |